The Delaware-based company combines biology with multi-core computation, algorithms, databases, and biological engineering to produce viable enzyme and protein candidates for industrial applications. Its computational platform optimizes the structure and function of proteins, enabling the development of a portfolio of genomics products for renewable energy, human health, industrial green chemistry, and environmental remediation. Evozym's enhanced enzyme technology includes protein and enzyme optimization, and novel compound development for biofuels, biopharmaceuticals, cleaning compounds, and bioremediation. The company intends to revolutionize statistical genomics to exploit new potentials for bioengineered protein design, bioremediation, and drug-targeting.